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CAN PANCREATIC PHLEGMON BE DIAGNOSED?
ABSTRACT
Fan, S-t., Choi, T-k., Chan, F-I., Lai, E.C.S. and Wong, J. (1989) Pancreatic
Phlegmon: What Is It? The American Journal of Surgery, 157 544-547
In a retrospective study of 264 patients with acute pancreatitis, 22 were identified as
having phlegmon by combined radiologic and clinical criteria. The radiologic
criteria consisted of demonstration of abnormal lesion on computed tomography
scan which was composed of masses of mixed density, free of extraluminal gas and
lacking a well-defined wail. The clinical criteria was that the clinical course was free
of sepsis. Half of the group thus identified had severe pancreatitis as defined as
having three or more poor prognostic signs. Fever, leukocytosis, and serum amylase
elevation persisted for a longer period than usual. Complication was infrequent but
the lesion could persist for 3 to 4 months without producing symptoms. This is a
relatively benign condition and surgery should be avoided
PAPER DISCUSSION
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The term phlegmon seems to excite great interest among those attempting to
describe acute pancreatitis and to understand its variegated clinical course. In large
part that interest has been in trying to prove that the term is either bad or unuseful.
There clearly has been no agreement on what the term means. Its original
proponents used it primarily to denote a sterile process, with varying amounts of
necrosis, but they also recognized that occult infection could be present or that
infection could develop at a later time in the evolution of the disease. 1’2
In the study by Fan et al., the authors describe 22 patients who met their criteria
of an abnormal inflammatory mass involving the pancreas and varying amounts of
peripancreatic tissues, but without evidence of either pseudocyst or infection.
Necrosis of the involved tissues was present in some of the cases and was associated
with multi-system organ failure in four patients and death in three of those.HPB INTERNATIONAL 301
Secondary infection occurred in at least one patient, but perhaps would have been
seen more frequently had antibiotics not been administered routinely. By definition
and intent (and even with further selection in hindsight) these, investigators
eliminated patients with infected necrosis from their study group, thereby sharply
skewing the possibility of finding infection in the series. In contrast Beger et al.
reported a prevalence ot infection of nearly 40% in pancreatic and peripancreatic
necrosis at the time of surgical debridement, findings which are very similar to
those of Gerzof et al.
4 who studied pancreatic inflammatory masses with percuta-
neous needle aspiration (with no false-positives and no introduction of infection).
Beger’s group also showed that the clinical and hemodynamic manifestations of
necrotizing pancreatitis are virtually indistinguishable whether or not infection is
present. What is clear from these studies is that the infection can be occult and that
infected inflammatory masses may only be separated from sterile inflammation by
direct bacteriological culture of the tissues, not by appearance alone. What is not
yet known is-how much necrotic tissue is tolerable or how to select those patients
likely to heal without debridement and those for whom the risk of complication,
including secondary infection, outweighs the risk of a surgical clean-out.
It has been my view that the element of uncertainty must be acknowledged by
clinicians treating patients with acute pancreatitis.
6 It would be desirable (and
soothing to our anxieties) to have black-and-white definitions and consequent
absolute guidelines for treatment, but that is not what happens in the real world.
The outcome of acute pancreatitis is unpredictable in a substantial number of
patients. Patients with extreme fluid shifts of severe early pancreatitis, even to the
point of shock, can recover without complication, while patients with a less
impressive presentation can evolve to severe tissue injury, sepsis, and death. The
prognostic scoring systems-Ranson, Glasgow, Bank, etc.-may be valid on a
statistical basis for groups of patients, but all are unreliable predictors for individual
patients. Sostre and his colleagues
7 made that point in their study of the phlegmon"
the outcome could range from spontaneous resolution to complication, including
later development of pseudocysts, abscesses, and death. It is agreed that most
patients heal a phlegmon and do not need surgical intervention, but some do
require that extra help. Even in the current study only 13 of the 22 patients had
uncomplicated resolution of the process.
I continue to suggest that the major advantage of the term phlegmon should be
its implication of uncertainty, of fragile truth which can change tomorrow, of the
need to maintain vigilance lest the next act of the play go unobserved. Pancreatitis
involves a temporal chain of events and injuries" early hemodynamic events, tissue
necrosis, and later infection. These may be compressed into a few days or develop
over a period of weeks. There is no evidence that a CT scan done on any single day
(even with contrast enhancement)
8 can predict that entire course. Diagnosis of a
phlegmon should imply only an interim impression and a provisional approach to
therapy. It is the middle of the story, not its end.
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